In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

In Person in Paris and online EuroPCR celebrates the best of both worlds

Interventional Cardiology

From 17-20 May 2022, a new Blended version of the World-Leading annual Course in interventional cardiovascular medicine will be taking place in Paris and all over the world.

EuroPCR is celebrating being back home in Paris, in-person, for the first time in 3 years. This year’s international Course will see both a complete on-site programme and a full digital experience, bringing the community together to share and learn.

As the official annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), EuroPCR is a patient-oriented Course built by and for the community covering the latest innovations and advances in cardiovascular interventions. Interventional cardiologists, cardiac surgeons, imaging specialists, radiologists, nurses, allied professionals and other practitioners will be joined by researchers, innovators and industry representatives to address interventions for coronary and peripheral vessels, for structural heart disease including valves, for hypertension, heart failure and stroke.

As one PCR catchphrase has it, ‘it’s all about the patient’. But it’s also ‘all about learning’, and over the challenging years between the last in-person EuroPCR in 2019 and this one, a lot has been learned, notably just how powerful digital can be. Online learning at EuroPCR has made a decade’s progress in just a couple of years and much effort has gone into ensuring an enriched experience for everyone at EuroPCR 2022: both online participants accessing exclusive content, and the participants in Paris, getting even wider, even more diverse input from colleagues all over the world.

EuroPCR 2022 is more than just on-line and in-person, it’s fully blended, with all participants encouraged to share comments and ask questions during live-streamed sessions in real time (orally or via the mobile app for in-person participants and via the chat for those online). And on the priority digital side, there’s the new concept « EuroPCR+ », a digital channel broadcasting live news, discussions and interviews, with repeat broadcasts 24 hours a day, giving participants the chance to catch up with the big news of each day and get in-depth scientific insight into key topics. 

A key element of the Course will be the opportunity for hands-on experience in the Training Village and Simulation-based learning, while presentations of the latest devices and sessions on innovation in cardiovascular medicine - such as artificial intelligence and the cath lab of the future - will generate much interest.

Over 700 participants will see their scientific abstracts, clinical cases, images, innovations and late-breaking trials showcased, with awards given for the best abstract presentation, the best clinical case, the best innovation and the best personalised vascular care project.

Key features:
• 4-day Course
• 21 session rooms, including 3 TV studios streaming live
• 10 digital channels
• A 24 hour/day digital channel (EuroPCR+)
• 300+ educational sessions
• 400+ hours of Programme content
• the return of real time LIVE cases from 4 LIVE Centres
• 1,680+ submissions received
• 70+ Industry booths

A global outreach:
• 45 National Societies and Working Groups in the onsite Scientific Programme
• 107 Countries represented by Course participants as of 27 April
• 63 Countries represented by the Core Team and Faculty
• 750+ Presenters from 78 different countries
• 4 LIVE Centres in 3 different countries
• 38 Official EuroPCR Ambassadors spread over 6 continents
• 3 TV studios in Paris live streaming sessions for worldwide access

Some highlights from the 400 hours of programme content in the upcoming Course
Hot Line sessions
The latest data from internationally recognised trials will be released at EuroPCR 2022 during dedicated Hot Line and Late-breaking Trial sessions.

Other sessions of interest
The return of LIVE cases with: NSTEMI PCI, OCT in MVD PCI, robotic PCI, TAVI and transcatheter mitral edge interventions. 

Simulation-based learning on topics such as: Image-guided bifurcation stenting - live from Japan; Antegrade CTO; TAVI; Bifurcation techniques; Transseptal puncture for mitral interventions. 

Special Sessions: 20 years of TAVI; The Cathlab of Tomorrow, already here Today; Hypertension Management. 

A programme dedicated to Nurses and Allied Professionals, onsite and live-streamed. 

The EAPCI-PCR Fellows Course, a track taking place throughout the four days. 

PCR Innovators Day, following which the Jon DeHaan Foundation will be rewarding the best innovation with a generous $200,000 grant.

The return of the renowned PCR’s Got Talent competition.

A Celebration
The theme for this year’s Course is “Let’s Celebrate”, in particular the joy of being “back home” in Paris, meeting face to face, but there are also several anniversaries to be celebrated:

20 years since the first Transcatheter Aortic Valve Implantation (TAVI) was performed by Professor Alain Cribier at the Charles Nicolle University Hospital in Rouen, France.
30 years since Dr Ferdinand Kiemeneij performed the first successful transradial coronary angioplasty procedure at Onze Lieve Vrouw Gasthuis in Amsterdam, Netherlands.
The 17th World Hypertension Day on 17th May.
The 10th anniversary of the EAPCI-PCR textbook, the first of its kind, all-inclusive patient-centred reference book promoting good, evidence-based clinical practices.
The 200th issue of EuroIntervention, the official journal of EuroPCR and the EAPCI was published in January 2022.
And it’s the 20th anniversary of the digital gateway to PCR, PCRonline.

Notes to editor

About EuroPCR 2022
The World-Leading Course in interventional cardiovascular medicine and the official annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) will take place from 17 to 20 May 2022, in Paris and online. The detailed Course Programme is available on:


About PCR
The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. PCR offers a large range of many other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include major annual Courses across the globe, e-Learning with high-profile PCR Webinars, Courses specifically dedicated to valvular heart disease, tailor-made PCR Seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI.
Gateways to all PCR activities are available on

For further information, please contact Sally Collingridge, PCR Marketing Communication Manager:


About the EAPCI
The European Association of Percutaneous Cardiovascular Interventions (EAPCI) is a branch of the European Society of Cardiology. Its mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions. This dynamic association represents a community of over 7,000 healthcare professionals by helping them remain up to date in the constantly evolving field of PCI by publishing research and providing training and certification programmes. The EAPCI also advocates for the best possible access to life saving treatments for patients through data-based advocacy at a European level.

Register and attend EuroPCR 2022 as a journalist
Open to accredited journalists, free of charge. Journalists must hold a valid press card and/or provide a letter of assignment from a recognised publication. To register as press, go to
EuroPCR press releases can be found at
For any press-related enquiries, please contact
EuroPCR Press Coordinator, Isabelle Uzielli: